Component

Woodchuck hepatitis virus and duck hepatitis B virus replication

Replication of two animal hepadnaviruses tested alongside hepatitis B virus.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. (-)-Lariciresinol dose-dependently inhibited other animal hepadnaviruses, including woodchuck hepatitis virus and duck hepatitis B virus.

    Experimental context and source evidence
    duration
    Not stated here
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    experimental_model
    Cell systems carrying woodchuck hepatitis virus and duck hepatitis B virus
    exposure
    (-)-Lariciresinol, dose-dependent
    limitations
    Activity across three hepadnaviruses is consistent with a host target rather than a viral enzyme, but the abstract does not give the concentrations or the size of the reduction for each virus.
    organism
    Cell systems carrying woodchuck hepatitis virus and duck hepatitis B virus
    plain_language
    (-)-Lariciresinol dose-dependently inhibited other animal hepadnaviruses, including woodchuck hepatitis virus and duck hepatitis B virus.
    primary_references
    (-)-Lariciresinol Isolated from the Roots of Isatis indigotica Fortune ex Lindl. Inhibits Hepatitis B Virus by Regulating Viral Transcription. (2022). https://pubmed.ncbi.nlm.nih.gov/35630700/ DOI: 10.3390/molecules27103223
    route
    In vitro
    tissue
    Hepadnaviral replication across species

    (-)-Lariciresinol and hepatocyte nuclear factor 1 alpha: the host-factor step (2026-09-22) · lines 22–31

    Original AI-assisted curation of twelve primary studies, every abstract read and all DOIs cross-checked against live PubMed metadata. Mechanism edges only, with no conclusion or claim of benefit recorded. Three author clusters account for eight of the twelve and carry shared laboratory keys. Study-specific concentrations, negative findings and limitations retained. Not publisher full text. · supports · · source_derived_draft · unverified_draft

    ## minus-lariciresinol-inhibits-other-hepadnaviruses (-)-Lariciresinol dose-dependently inhibited other animal hepadnaviruses, including woodchuck hepatitis virus and duck hepatitis B virus. Model/species: Cell systems carrying woodchuck hepatitis virus and duck hepatitis B virus Tissue/system: Hepadnaviral replication across species Exposure: (-)-Lariciresinol, dose-dependent Route: In vitro Duration: Not stated here Limits: Activity across three hepadnaviruses is consistent with a host target rather than a viral enzyme, but the abstract does not give the concentrations or the size of the reduction for each virus. Primary reference: (-)-Lariciresinol Isolated from the Roots of Isatis indigotica Fortune ex Lindl. Inhibits Hepatitis B Virus by Regulating Viral Transcription. (2022). https://pubmed.ncbi.nlm.nih.gov/35630700/ DOI: 10.3390/molecules27103223 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards